You have 9 free searches left this month | for more free features.

Multiple Myeloma

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Jul 31, 2023

Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Multiple Myeloma M-Protein Analysis
  • Multiple Myeloma Knowledge Questionnaires
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 26, 2023

Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Sep 20, 2023

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

Recruiting
  • Multiple Myeloma
  • APRIL-BAFF-Bicephali CAR-T cells
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 14, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
Aug 8, 2023

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

Not yet recruiting
  • Multiple Myeloma
  • Miami, Florida
    University of Miami
Oct 20, 2023

Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Belantamab mafodotin, Venetoclax
  • (no location specified)
May 10, 2023

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2023

Real-World Mapping Antithrombotic Regimens in MM Patients on

Not yet recruiting
  • Multiple Myeloma
  • Diagnosis
    • (no location specified)
    Aug 31, 2023

    Multiple Myeloma Trial in Paris (Idecabtagene vicleucel, Not treated)

    Active, not recruiting
    • Multiple Myeloma
    • Idecabtagene vicleucel
    • Not treated
    • Paris, France
      DESCAR-T Registry
    Nov 27, 2023

    Alvocade® (Bortezomib) Safety and Effectiveness Study

    Completed
    • Multiple Myeloma, Refractory
    • (no location specified)
    Aug 19, 2023

    Multiple Myeloma Trial in Saint Louis (Care transition, No care transition)

    Not yet recruiting
    • Multiple Myeloma
    • Care transition
    • No care transition
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 30, 2023

    Multiple Myeloma Trial (Patient Reported Outcomes)

    Not yet recruiting
    • Multiple Myeloma
    • Patient Reported Outcomes
    • (no location specified)
    Apr 24, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ISB 2001
    • Benowa, Queensland, Australia
      Pindara Private Hospital
    May 18, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

    Not yet recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Miami, Florida
      University of Miami
    May 31, 2023

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023

    Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

    Recruiting
    • Lymphoma
    • Multiple Myeloma
    • pegylated recombinant human granulocyte-colony stimulating factor
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Sep 23, 2023

    Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

    Not yet recruiting
    • Multiple Myeloma
    • Supportive Care (home-based physical activity)
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 22, 2023

    Multiple Myeloma Trial in São Paulo (Single-dose involved-site radiotherapy)

    Recruiting
    • Multiple Myeloma
    • Single-dose involved-site radiotherapy
    • São Paulo, Sao Paulo, Brazil
      University of Sao Paulo
    Aug 9, 2023

    Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • Auricular Acupuncture
    • (no location specified)
    Mar 7, 2023

    Optical Genome Mapping in Characterization of Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Bone Marrow samples collection
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Mar 15, 2023